Brigham and Women's investigates "affinity birth" in B cells to expand antibody repertoire plasticity
Brigham and Women's Hospital has received a USD 3 million NIH R01 grant from the National Institute of Allergy and Infectious Diseases to investigate whether B cells lacking initial antigen specificity can acquire new antibody recognition through somatic hypermutation — a process the investigators term "affinity birth".
The four-year award, running through May 2030, funds work by principal investigator Duane R. Wesemann into a hypothesis that challenges a foundational assumption of adaptive immunity: that somatic hypermutation (SHM) refines pre-existing antigen recognition rather than generating it de novo. Germinal center B cells that lack measurable antigen binding are conventionally considered bystanders, unlikely to contribute meaningfully to affinity maturation. The funded research will examine whether these non-specific B cells can nonetheless undergo SHM-driven mutation and selection, acquiring new specificities through what the grant describes as a combinatorial expansion of accessible immunoglobulin variable gene segments.
If supported, the concept would suggest the germinal center reaction is more permissive — and the antibody repertoire more plastic — than current models indicate. The translational implications are most direct for vaccine design: understanding whether and how new specificities can emerge from initially non-reactive B cell populations could inform immunogen strategies targeting pathogens where the pre-immune repertoire offers limited coverage, including HIV-1, which is referenced in the grant's scientific terms.
The NIAID R01 reflects sustained institutional investment in germinal center biology at a time when rational vaccine design — particularly for highly mutable pathogens — remains a central challenge. Wesemann's laboratory at Brigham and Women's is positioned within a dense Boston-area immunology ecosystem that includes competing and complementary programs at Harvard Medical School, MIT, and the Ragon Institute.
This article was generated with AI assistance and reviewed and edited by the AllSci editorial team Explore more at AllSci News: https://allsci.com/news/
Spot something wrong? Report an issue with this article
Summary
Brigham and Women's Hospital has received a USD 3 million NIH R01 grant from the National Institute of Allergy and Infectious Diseases to investigate...